BY HARSH V. PANT, AARSHI TIRKEY
If the COVID-19 pandemic has taught us anything, it is that global responses are needed to confront diseases that can spread around the world with stunning speed. It is no wonder, then, that the concept of global health diplomacy—including vaccine diplomacy—has become a major foreign-policy talking point everywhere from China to the United States.
Yet rhetoric aside, the predominant response to the disease has been to shut down and look inwards. As the global demand for medicines, medical supplies, and personal protection equipment increased, countries imposed export prohibitions and restrictions to stabilize domestic supplies. Vaccine nationalism was soon to follow, with the possibility that rich countries would attempt to hoard vaccines by striking pre-purchase deals with pharmaceutical companies.
Throughout it all, though, it was always clear that a global challenge of this magnitude would eventually require a global solution, based on international health cooperation between public and private-sector stakeholders. And Indian Prime Minister Narendra Modi recognized early on that his country could play a unique role in that process.